FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to an agent retaining a population of GABA-ergic neurons after acute perinatal hypoxia. Claimed agent comprises 4-amino-3-phenylbutanoic acid with salicylic acid in a molar ratio (1–3):1.
EFFECT: implementation of the invention makes it possible to obtain a low-toxic agent preserving the population of GABA-ergic neurons after acute perinatal hypoxia.
1 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT HAVING A PROPERTY TO PREVENT DEATH OF GABA-ERGIC NEURONS IN CONDITIONS OF ACUTE PERINATAL HYPOXIA | 2017 |
|
RU2672918C1 |
| AGENT POSSESSING CEREBRAL-PROTECTIVE, ENDOTHELIAL-POSITIVE AND ANTITHROMBOTIC EFFECT | 2015 |
|
RU2594254C1 |
| AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
| METHOD OF THE TREATMENT OF THE BRAIN IN ACUTE HYPOXIA WITH HYPERCAPNIA | 2022 |
|
RU2803387C1 |
| AGENT POSSESSING CARDIOPROTECTIVE, ANTIPLATELET, ANTICOAGULANT AND MEMBRANE-PROTECTIVE PROPERTIES UNDER STRESS STIMULATION | 2013 |
|
RU2531080C1 |
| METHOD FOR PREVENTING AND CORRECTING METABOLIC AND FUNCTIONAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM UNDER STRESS CONDITIONS | 2019 |
|
RU2717107C1 |
| AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
| AGENT POSSESSING ENDOTHELIUM PROTECTIVE EFFECT IN CONDITIONS OF EXPERIMENTAL DIABETES MELLITUS AND CEREBRAL BLOOD CIRCULATION DISORDER | 2015 |
|
RU2601622C1 |
| METHOD FOR SIMULATING PRENATAL HYPOXIC ENCEPHALOPATHY IN SMALL LABORATORY ANIMALS | 2012 |
|
RU2497202C1 |
| METHOD FOR PREVENTION OF PERINATAL CENTRAL NERVOUS SYSTEM DAMAGE IN NEWBORN INFANTS | 2012 |
|
RU2517162C2 |
